Previous studies have shown that microRNA-1304 (miR-1304) is dysregulated in certain types of cancers, including non-small cell lung cancer (NSCLC), and might be involved in tumor survival and/or growth. In this study we investigated the direct target of miR-1304 and its function in NSCLC in vitro. Human lung adenocarcinoma cell lines (A549 and NCI-H1975) were studied. The cell proliferation and survival were investigated via cell counting, MTT and colony-formation assays. Cell apoptosis and cell cycle were examined using annexin V-PE/7-AAD and PI staining assays, respectively. The dual-luciferase reporter assay was used to verify post-transcriptional regulation of heme oxygenase-1 (HO-1) by miR-1304. CRISPR/Cas9 was used to deplete endogenous miR-1304. Overexpression of MiR-1304 significantly decreased the number and viability of NSCLC cells and colony formation, and induced cell apoptosis and G 0 / G 1 phase cell cycle arrest. HO-1 was demonstrated to be a direct target of miR-1304 in NSCLC cells. Restoration of HO-1 expression by hemin (20 μmol/L) abolished the inhibition of miR-1304 on cell growth and rescued miR-1304-induced apoptosis in A549 cells. Suppression of endogenous miR-1304 with anti-1304 significantly increased HO-1 expression and promoted cell growth and survival in A549 cells. In 17 human NSCLC tissue samples, miR-1304 expression was significantly decreased, while HO-1 expression was significantly increased as compared to normal lung tissues. MicroRNA-1304 is a tumor suppressor and HO-1 is its direct target in NSCLC. The results suggest the potential for miR-1304 as a therapeutic target for NSCLC.
Introduction
Lung cancer is one of the leading causes of cancer-related death. Non-small cell lung cancer (NSCLC) accounts for >80% of lung cancer cases and currently has an overall five-year survival rate of only 15% [1] . Although treatment strategies such as surgical resection, chemotherapy and radiotherapy have made great progress in recent decades, the survival rates for NSCLC have not been effectively improved [2] . Therefore, the discovery of early, safe and noninvasive detection methods is important for screening and diagnosis, and new therapies and treatment targets are in demand.
MicroRNAs (miRNAs) are endogenous, small non-coding RNAs that are approximately 22 nucleotides in length. MiRNAs regulate gene expression at the post-transcriptional level by binding to the 3' untranslated regions (3'UTR) of target mRNAs [3] [4] [5] . In mammals, miRNAs are predicted to modulate the expression of more than 60% of all protein-coding genes and thus play an important regulatory role in almost every cellular process, including cell differentiation, proliferation, apoptosis, invasion and migration [6] [7] [8] . Numerous studies have reported that expression of certain miRNA(s) is dysregulated in different tumor types, including lung cancer, and miRNAs have emerged as important players in tumorigenesis and cancer development [9] . Previous studies have reported that miR-1304 expression is dysregulated in paclitaxel-treated hypopharynx cancer and
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MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1 Bcl-xl silenced NSCLC [10, 11] . Those studies suggested that miR-1304 might be involved in tumor survival and/or growth. However, the role of miR-1304 in NSCLC remains unclear. Although certain target genes of miR-1304 have been predicted and detected in other types of cells [10, 12] , the direct target of miR-1304 and its function in NSCLC remain to be clarified. In this study, we investigated the function and target of miR-1304 in NSCLC.
Materials and methods
Cell lines and culture conditions Human lung adenocarcinoma cell lines (A549 and NCI-H1975) were acquired from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in RPMI-1640 (Invitrogen, Carlsbad, CA, USA) medium supplemented with 10% fetal bovine serum (FBS) and kept in a humidified incubator at 37 °C with 5% CO 2 .
Transfection of microRNA mimics and HO-1 siRNA The miR-1304 mimics (5'-UUUGAGGCUACAGUGAGA-UGUG-3'), its mutant (5'-UAACUCCCUACAGUGAGA-UGUG-3'), and HO-1 siRNA duplexes were purchased from GenePharma (Shanghai, China). The synthetic siRNA target sequence is 5'-CAGUUGCUGUAGGGCUUUATT-3'. Transient transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
Cell counting and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay Cells were counted using a Vi-cell XR cell viability analyzer (Beckman Coulter, Brea, CA, USA). Cell viability was determined using the MTT assay. In brief, cells were harvested following 24 h of transfection and plated at 2×10 3 cells per well in 96-well plates. Following incubation, 20 μL of MTT reagent (5 mg/mL) was added into each well, and the cells were incubated in the dark at 37 °C for 4 h. Then, 100 μL of dissolution buffer was added into each well and incubated overnight. Absorbance was measured at 570 nm using a microtiter plate reader (Bio-Tek Instruments, Winooski, VT, USA).
Colony-formation assay
Twenty-four hours after transfection with miR-1304 mimics or negative control oligonucleotides, the NSCLC cells were seeded in 6-well plates and grown for ten days for the colonyformation assay. The cells were washed with PBS, fixed with methyl alcohol, stained by Geisma and photographed using a Typhoon FLA 9500 instrument (GE Healthcare, Little Chalfont, UK). Colonies were counted using ImageQuant TL (GE Healthcare, Little Chalfont, UK).
Annexin V-PE/7-AAD apoptosis and cell cycle assay Apoptotic cells were examined using the PE Annexin V Apoptosis Detection Kit I (BD Biosciences, San Jose, CA, USA). The cells were harvested and stained with 5 μL of annexin V-PE and 5 μL of 7-AAD for 15 min at room temperature in the dark. Cell cycle distribution was analyzed by PI staining assay. Fixed cells were treated with RNase A and stained with PI. The cells were measured using a BD FACS flow cytometer (BD Biosciences, San Jose, CA, USA) according to the manufacturer's instructions.
Western blot
Cells were harvested, and protein lysates were separated using 12% SDS-PAGE, transferred to PVDF membranes (Millipore, Billerica, MA, USA) and incubated with a primary antibody against HO-1 (Enzo Life Sciences, ADI-SPA-896-D, USA) or β-actin (sc-47778; Santa Cruz Biotechnology, Dallas, TX, USA) as an internal control. The density of the bands was quantified using ImageQuant 5.2 software (GE Healthcare, Little Chalfont, UK).
RNA isolation and quantitative RT-PCR
Total RNA was extracted from cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. For HO-1 expression, reverse transcription was performed with PrimeScript RT Master Mix (TaKaRa Biotechnology, Dalian, China) following the manufacturer's instructions. Reverse transcription (RT) reactions contained 0.5 μg of total RNA samples and 4 μL of PrimeScript RT Master and were topped off to 20 μL with DEPC treated water. The thermal profile for RT consisted of incubation at 37 °C for 15 min and termination of the reaction at 85 °C at 5 s. One microliter of undiluted cDNA was used in the RT-qPCR protocol. Quantitative real-time PCR (RT-qPCR) was performed with the QuantiNova SYBR Green PCR kit (Qiagen, Valencia, CA, USA). RT-qPCR reactions contained 10 μL of SYBR Green PCR Master Mix, 0.4 μL of forward primer (10 μmol/L), and 0.4 μL of reverse primer (10 μmol/L) and were topped off to 20 μL with DEPC-treated water. RT-qPCR was analyzed on RotorGene Q 2plex HRM System (Qiagen, Valencia, CA, USA). PCR reactions were performed in triplicate for each sample. The PCR thermal profile consisted of one activation step (90 °C for 1 min), followed by 35 cycles of denaturation at 95 °C for 10 s, annealing and extension at 60 °C for 40 s and subsequent melting curve analysis. The relative HO-1 mRNA levels were analyzed by normalizing the threshold cycle (Ct) value to that of the internal loading control, β-actin. The following primers were used: HO-1 forward, 5'-GCCAGCAACAAAGTG-CAAG-3' and reverse, 5'-GAGTGTAAGGACCCATCGGA-3'; β-actin forward, 5'-GGCTACAGCTTCACCACCAC-3' and reverse, 5'-GAGTACTTGCGCTCAGGAGG-3'.
To quantify miR-1304, the expression level of miR-1304 was measured using the NCode™ VILO miRNA cDNA Synthesis Kit and EXPRESS SYBR Green ER miRNA qRT-PCR Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The PCR thermal profile consisted of two activation steps (50 °C for 2 min, 90 °C for 2 min), followed by 40 cycles of denaturation at 95 °C for 15 s, annealing and extension at 60 °C for 40 s and subsequent melting curve analysis. U6 snRNA were used as an internal loading control. Dual luciferase reporter assay A full length of human HO-1 3'UTR was amplified and cloned into the Renilla psi-CHECK2 vector (Promega). Mutations in the 3'UTR were generated using a KOD-Plus-Mutagenesis kit (Toyobo). Cells seeded in 6-well plates were co-transfected with miR-1304 mimics (25 nmol/L) or negative control and reporter constructs (0.5 μg) using Lipofectamine 2000. Cell extracts were prepared 48 h after transfection, and luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega).
CRISPR/Cas9-mediated miR-1304 knockdown CRISPR/Cas9-mediated nucleotide deletion was performed as previously described [13] . Two sgRNAs (5'-caccgtcactgtagcctcaaaccgc-3'; 5'-caccgaggctacagtgagatgtggc-3') were cloned into px330-mCherry and px330-GFP vectors, respectively. The plasmids were co-transfected into A549 cells, and positively transfected cells were isolated using flow cytometry and used in the following experiments.
Statistical analysis
All statistical analysis were performed using GraphPad Prism software (version 5.01; GraphPad Software, Inc, CA, USA). The data are shown as the mean values with standard error of the mean (SEM), and P<0.05 was considered statistically significant. All experiments were performed independently at least three times. The significance of differences between two groups was measured using Student's t-test. One-way analysis of variance (ANOVA) was used to measure the significance of comparisons for more than two groups.
Results
Ectopic miR-1304 expression suppresses cell growth and survival of NSCLC cells by inducing cell apoptosis and cell cycle arrest To characterize the function of miR-1304 in NSCLC, A549 and NCI-H1975 cells were transiently transfected with miR-1304 mimics. RT-qPCR analysis confirmed that mature miR-1304 was successfully overexpressed in cells transfected with miR-1304 mimics ( Figure 1A ). Ectopic miR-1304 expression markedly inhibited growth of A549 and NCI-H1975 cells ( Figure  1B ). In the colony-formation assay, the colony-forming activities of both A549 and NCI-H1975 cells transfected with miR-1304 mimics were inhibited compared with negative control oligonucleotides ( Figure 1C, 1D) . To further investigate the function of miR-1304 in the survival of NSCLC cells, we performed an MTT assay to examine the viability of NSCLC cells. The results showed that the viability of A549 and NCI-H1975 cells transfected with miR-1304 mimics was clearly decreased ( Figure 1E, 1F ). These data demonstrated that miR-1304 was able to suppress the growth of NSCLC cells.
Flow cytometry assays were performed to determine the effects of miR-1304 on apoptosis and the cell cycle of NSCLC cells. As shown in Figure 1G , miR-1304 overexpression led to a significantly increased ratio of apoptotic cells. Cell cycle analysis by flow cytometry based on propidium iodide (PI) staining revealed that transfection with miRNA-1304 mimics in A549 and NCI-H1975 cells increased the percentage of cells in the G 0 /G 1 phase ( Figure 1H ). Taken together, these data suggested that miR-1304 suppressed cell growth and survival by inducing cell apoptosis and cell cycle arrest in the G 0 /G 1 phase.
HO-1 is a direct target gene of miR-1304
Next, we sought the target of miR-1304, which mediates its inhibitory effects on cell growth and apoptosis. In silico analysis using the database TargetScan (http://www.targetscan. org/) identified HO-1 as a direct target gene of miR-1304. Heme oxygenase-1 (HO-1) catalyzes the rate-limiting step in heme degradation by converting heme to carbon monoxide (CO), free iron and biliverdin. Numerous reports have shown that the expression of HO-1 was higher in cancer cells than in the surrounding healthy tissue. Additionally, HO-1 is believed to exert a cancer cell growth-promoting effect. As shown in Figure 2A , the 3'UTR of HO-1 mRNA contains a putative site that is complementary to the seed region of miR-1304. To confirm that HO-1 is the direct target of miR-1304, a dual luciferase reporter assay was performed. Our results showed that miR-1304 significantly inhibited the luciferase activity of the wild-type (wt) 3'UTR of HO-1 but had no inhibitory effect on the mutant form (mt) ( Figure 2B) . Similarly, the inhibition effect on HO-1 3'UTR activity was abolished when miR-1304 was mutated in the seed region (5'mt) ( Figure 2C ). Western blot and RT-qPCR analyses were performed to detect the effects of miR-1304 on HO-1 expression at the protein and mRNA levels, respectively. The results showed that miR-1304 mimics but not its mutant form significantly inhibited HO-1 protein and mRNA expression ( Figure 2D , 2E) in A549 and NCI-H1975 cells. These results indicated that HO-1 is a direct target of miR-1304 and is negatively regulated by miR-1304 in NSCLC cells.
HO-1 plays a critical role in miR-1304-mediated growth suppression of NSCLC cells The data presented above suggest that miR-1304 negatively regulates the expression of HO-1 protein and mRNA by targeting its 3'UTR. Most mammalian cells induce HO-1 upon stimulation with hemin. To explore whether HO-1 is involved in modulating NSCLC cell survival, we restored the expression of HO-1 in miR-1304-transfected A549 cells via treatment of the cells with 20 μmol/L hemin, as previously described [14] . We evaluated the levels of HO-1 protein in A549 cells transfected with miR-1304 alone or in the presence of hemin, and we found that the reduction of HO-1 expression by miR-1304 was abolished by hemin ( Figure 3A) . Hemin-mediated HO-1 re-expression attenuated miR-1304-promoted growth of NSCLC cells ( Figure 3B-3D) . MiR-1304-induced cell apoptosis and G 0 /G 1 phase cell cycle arrest were also abolished in hemin-treated cells ( Figure 3E, 3F) . We used RNAi to study the effect of HO-1 loss of function on NSCLC cell growth. The results showed that in A549 and NCI-H1975 cells transfected with small-interfering RNA against HO-1 (siHO-1), HO-1 pro- Figure 3G ). Upon downregulation of HO-1 by siHO-1, the number of NSCLC cells was significantly reduced ( Figure  3H ), and cell viability was inhibited ( Figure 3I, 3J) . These results of cell viability upon HO-1 knockdown were consistent with that of miR-1304 transfection in NSCLC cells. To further demonstrate that miR-1304 directly targets HO-1, we co-transfected siHO-1 with miR-1304 mimic into A549 cells. Strikingly, transfection with siHO-1 and miR-1304 together led to a 23% greater reduction in cell numbers compared with siHO-1 transfection alone ( Figure 3K ). We also analyzed HO-1 protein expression in these cells and found that a greater HO-1 suppression effect was observed in cells co-transfected with siHO-1 and miR-1304, which was in accordance with the cell number inhibition effect ( Figure 3L ). These results supported the explanation that miR-1304 suppresses growth of NSCLC cells by targeting HO-1.
Endogenous miR-1304 suppresses NSCLC cell growth
We were also interested in whether endogenous miR-1304 plays a pathophysiological role in NSCLC cells. First, RTqPCR was used to assess endogenous miR-1304 and HO-1 expression in NSCLS cell lines, as shown in Figure 4A , A549 cells have a relatively low level of miR-1304 and a high level of HO-1. Transfection of A549 cells with anti-sense oligonucleotides against miR-1304 (Anti-1304) resulted in a 24% decrease in miR-1304 expression compared with cells transfected with negative control oligonucleotides (Anti-nc) ( Figure  4B ). Accordingly, HO-1 expression, cell numbers, colonyforming efficiency and cell viability were slightly enhanced in A549 cells transfected with Anti-1304 ( Figure 4C-4F) . Flow cytometry analysis revealed that transfection with anti-1304 in A549 cells decreased the percentage of apoptotic and G 0 /G 1 phase cells (Figure 4G, 4H) . To further determine the relationship between miR-1304 and HO-1, we used CRISPR/Cas9 to knockdown endogenous miR-1304. The results showed that miR-1304 was dramatically reduced in cells with miR-1304 knocked down by CRISPR/Cas9 (Figure 4J) , and the mRNA and protein expression levels of HO-1 increased significantly in these cells ( Figure 4K, 4L) .
These results provided further evidence that miR-1304 suppresses growth of NSCLC cells by targeting HO-1.
MiR-1304 is down-regulated in human NSCLC tissues
To investigate the pathophysiological role of miR-1304 in human lung carcinogenesis, we evaluated the expression of miR-1304 and HO-1 in seventeen frozen human NSCLC tissues and ten normal human lung tissues using RT-qPCR. The expression level of miR-1304 in tumor tissues was significantly lower than in normal lung tissues ( Figure 5A ), whereas HO-1 was up-regulated in tumor tissues compared with normal lung tissues, although no statistically significant difference was found ( Figure 5B), probably due to the small sample size.
These findings suggested that decreased miR-1304 and increased HO-1 expression might be responsible for NSCLC growth.
Discussion
MicroRNA dysregulation has been observed in various pathological conditions, such as cancer. It plays an important role in cancer development and progression by suppressing the expression of genes involved in cell proliferation, apoptosis, differentiation, invasion and metastasis. MicroRNAs are also considered potential targets for cancer treatment. Therefore, identification of tumor-related miRNAs and their direct target genes is critical to understanding the biological function of miRNA in cancer and might offer novel biomarkers or therapeutic targets for effective treatment of cancer. miR-1304 is a primate-specific miRNA that has low expression in human embryonic stem cells, peripheral blood, brain cortex, and melanoma [15] [16] [17] [18] . Recently, two studies indicated that miR-1304 might influence the cell viability in different cancer types. In paclitaxel-treated hypopharynx cancer cells, miR-1304 was found to be dramatically up-regulated coupled with decreased cell viability [10] . In contrast, miR-1304 was down-regulated in Bcl-xl silenced lung adenocarcinoma, and cell viability was reduced in the tumor [11] . These results suggest that miR-1304 might exert different roles via different pathways in response to different stimuli. Although certain targets have been reported and predicted [10, 12] , the direct target of miR-1304, by which it influences cancer cell viability, is still unclear. In our study, we found that miR-1304 decreased the number of NSCLC cells and suppressed cell viability and colony-formation ability. Furthermore, ectopic expression of miR-1304 led to a higher percentage of apoptotic cell and cells in G 0 /G 1 phase in vitro.
HO-1 was further identified as a new, direct and functional target of miR-1304 using miRNA target prediction software and experimental validation. Using dual-luciferase reporter assays, we found that miR-1304 could target the 3'UTR sequence of HO-1. In addition, miR-1304 but not its mutant form can inhibit HO-1 mRNA and protein expression. Moreover, we validated the importance of miR-1304/HO-1 axis via rescue experiments. Restoration of HO-1 expression abolished miR-1304-mediated cell growth suppression of NSCLC cells. Consistent with miR-1304 transfection, knockdown of HO-1 decreased the number of NSCLC cells and suppressed cell viability. In addition, we found that endogenous miR-1304 suppressed HO-1 expression. In miR-1304-inhibited cells, HO-1 expression, cell growth, colony-forming efficiency and cell viability were increased. Probably owing to the low level of endogenous miR-1304 in A549 cells and insufficient suppression efficiency of Anti-1304 antisense oligonucleotides, Anti-1304-induced changes in cell growth and colony formation were not significant. However, cell apoptosis was significantly suppressed by Anti-1304, which indicated that these cells were more sensitive to miR-1304 with respect to apoptosis. Decreased miR-1304 and increased HO-1 were detected in NSCLC tissues compared with related normal tissues.
Heme oxygenase-1 (HO-1), also known as Hsp32, catalyzes the rate-limiting step in heme degradation. HO-1 converts heme to carbon monoxide (CO), free iron and biliverdin, which is quickly reduced to bilirubin. Numerous studies have demonstrated the function of HO-1 in many types of cancer, including thyroid cancer [19] , acute myeloid leukemia [20] , breast cancer [21] , prostate cancer [22] , melanoma [23] , renal cancer [24] and non-small cell lung cancer [25] . Compared with surrounding healthy tissue, HO-1 is extensively expressed in tumor tissues, and HO-1 is believed to exert a cancer cell growth-promoting effect that is dependent on its three metabolites [26] and itself [27] . Consequently, several anticancer strategies aimed at HO-1 have been developed, and it has been clearly demonstrated that specific HO inhibitors such as metalloporphyrins present tumor inhibitory effects. However, clinical use of HO-1 inhibitors is limited because of various side effects [28] . Therefore, the development of novel HO-1 inhibitors is in great demand. MicroRNA, which suppresses gene expression at post-transcriptional level, offers a potential strategy. Several reports have found that miR-217, miR-377, miR-200c and miR-24-3p can directly interact with HO-1 3'UTR in hemin chloride-treated HEK293, human umbilical vein endothelial cells, clear-cell renal cell carcinoma cells and MARC-145 cells [14, 29, 30] . In this work, we found that microRNA-miR-1304 could significantly suppress the expression of HO-1 in NSCLC cells by targeting the HO-1 3'UTR.
In conclusion, we demonstrated that miR-1304 inhibited cell growth and decreased cell viability and colony-forming activity in NSCLC cells. Furthermore, miR-1304 most likely exerts its biological functions on NSCLC cell growth and viability by targeting HO-1. Our findings suggest that modulation of miR-1304/HO-1 expression offers a potential therapeutic strategy for NSCLC.
